— Know what they know.
Not Investment Advice

Financial News

Sentiment 46.2 5329 articles 2917 bullish 1267 bearish Full Index →
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Consensus

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Consensus Rating of “Hold” by Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received a consensus rating of “Hold” from the six ratings firms...
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of “Hold” b

Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of “Hold” by Brokerages

Shares of Novavax, Inc. (NASDAQ:NVAX – Get Free Report) have earned a consensus recommendation of “Hold” from the ten ratings firms...
Top Pharmaceutical Stocks To Watch Today – March 17th

Top Pharmaceutical Stocks To Watch Today – March 17th

Eli Lilly and Company, Pfizer, Vertex Pharmaceuticals, Novo Nordisk A/S, AbbVie, Abbott Laboratories, and Bristol Myers Squibb are the seven...
Top Pharmaceutical Stocks To Watch Today – March 17th

Top Pharmaceutical Stocks To Watch Today – March 17th

Eli Lilly and Company, Pfizer, Vertex Pharmaceuticals, Novo Nordisk A/S, AbbVie, Abbott Laboratories, and Bristol Myers Squibb are the seven...
Top Pharmaceutical Stocks To Watch Today – March 17th

Top Pharmaceutical Stocks To Watch Today – March 17th

Eli Lilly and Company, Pfizer, Vertex Pharmaceuticals, Novo Nordisk A/S, AbbVie, Abbott Laboratories, and Bristol Myers Squibb are the seven...
Medical Stocks To Follow Today – March 17th

Medical Stocks To Follow Today – March 17th

Eli Lilly and Company, UnitedHealth Group, Pfizer, Hims & Hers Health, and Masimo are the five Medical stocks to watch today, according to...
InMode Ltd. (NASDAQ:INMD) Receives Average Recommendation of

InMode Ltd. (NASDAQ:INMD) Receives Average Recommendation of “Hold” from Analysts

Shares of InMode Ltd. (NASDAQ:INMD – Get Free Report) have received an average rating of “Hold” from the nine ratings firms that...
« Prev 1 13 14 15 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms